Msg #4006:
Msg #4024:
Msg #4011:
Msg #4012:

We are a leading cancer diagnostics company with proprietary blood tests that help to realize the full potential of precision oncology. We provide patients and their providers critical insights that can inform decisions at all stages of the disease, from screening, to monitoring cancer recurrence, to treatment decisions. To help identify cancer at the earliest stages, we developed Shield™, the first and only FDA-approved blood test for colorectal cancer screening with Medicare coverage. Shield seeks to offer an accurate, easy to complete, blood-based approach to CRC screening. By leveraging data from the thousands of patients we’ve already tested, we have developed a test that demonstrates high sensitivity and specificity as well as high patient adherence rate.

Msg #4016:
Msg #4017:
Msg #4018:
Msg #4019:
Msg #4020:
Msg #4730: